Seres therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Seres therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 7.031 million compared to usd 9.055 million a year ago. operating loss was usd 17.183 million compared to usd 22.211 million a year ago. basic loss per share was usd 0.23 compared to usd 0.54 a year ago. net loss was usd 16.409 million compared to usd 21.949 million a year ago. for the nine months, total revenue was usd 26.883 million compared to usd 17.638 million a year ago. operating loss was usd 52.684 million compared to usd 78.613 million a year ago. basic loss per share was usd 0.99 compared to usd 1.91 a year ago. net loss was usd 51.501 million compared to usd 77.655 million a year ago.
MCRB Ratings Summary
MCRB Quant Ranking